|
Manufacturer ref#(b)(4).The purpose of this mdr submission is to report the findings of the device investigation.The delivery wire is separated, the findings meet usfda regulatory reporting criteria.Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section e1.Initial reporter phone: (b)(6).The device was returned to j&j medtech for further evaluation.A non-sterile enterprise2 4mmx16mm was received contained in the decontamination pouch.Upon receiving the device, visual inspection was performed and the distal end of the delivery wire was broken next to the retracting bump.The stent was not returned for evaluation.The broken condition of the delivery wire suggests that the delivery wire was pushed or retracted against resistance sufficiently to cause the delivery wire to break and disengage the stent.Therefore, the customer complaint can be confirmed.There is no indication that the issue reported in the complaint is a result of a defect inherently related to the device.The stent component might have gotten lost sometime during the post-operative handling or decontamination of the device.If additional information or components are received at a later time, this investigation will be reassessed accordingly.Lake region medical did review the device history records relative to the manufacturing, inspecting and packaging of the lot 9262192.The history records indicate this product was final inspection tested at lake region medical and was determined to be acceptable.As part of the j&j medtech quality process, all devices are manufactured, inspected, and released to approved specifications.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no capa activity is required.It should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) do contain the following recommendations: ¿ if resistance is met during manipulation, determine the cause of resistance before proceeding.¿ do not apply undue force if resistance is encountered at any point during stent manipulation.Withdraw the unit and advance a new one.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
It was reported that during an angioplasty procedure, an enterprise2 4mmx16mm (encr401612/ 92621920) stent was impeded in y connector and could not advance any more.The doctor only retracted the stent alone, and switched to a new stent to complete the surgery.The microcatheter was not replaced.There was no patient injury reported.Additional information received indicated that the event did not result in any undue procedural delay that could be considered clinically significant.The device did not appear damaged at any time.Based on the product analysis of the device received, the delivery wire is separated.
|